Redeye updates on Embracer following Q3-results where the company saw solid performance in PC/Consol...
Redeye updates its view on Genovis following the company's year-end report.
Redeye provides an update on AcouSort following its year-end report, which did not include any surpr...
Aspo reported a weak Q4 that was affected by low industrial activity and low spot prices in ESL, whe...
Redeye states that Acconeer’s Q4 2024 report was mixed, with a slight net sales miss, while EBITDA w...
Redeye retains its positive view of Carasent following the Q4 report.
Minor estimate revisions Swedish operations could fund future international growth Maintain fair val...
Redeye provides an update following SSH's Q4 2024 report.
6% organic sales decline y-o-y Finnish market is seeing signs of improvement Adj.
'25e-'26e EBITA down 7-5% Freight rate normalisation required for better gross margins '25e EV/EBITA...
2024 closed with record sales, EBIT and order intake Increased TAM assumptions prompt upgrades, EBIT...
Alisa Bank’s H2 financials corresponded to our expectations, although NII and subsequently total inc...
Redeye remains confident that Powercell is on a solid growth track.
Solteq’s Q4 results were weaker than expected. While the company maintained its profitability improv...
Wyld Networks has finally begun the first large-scale production of Satellite-IoT terminals.
CapMan’s Q4 results were better than expected through good investment returns.
Redeye comments on Active Biotech’s Q4 report. The main event in the quarter was the oversubscribed ...
Small signs pointing towards a system-wide deal in India At the presentation of the Q4’24 report, C...
Redeye's immediate take on Nanologica's year-end report is relatively undramatic.
Umida Group publicerade den 13 februari 2025 bolagets delårsrapport för det fjärde kvartalet år 2024...
